Skip to content

Clinical trials

Phase 2 Pancreatic Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 2 Country / region: Netherlands Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20101
20121
20131
20152
20161
20171
20192
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting4
Unknown status3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
European Organisation for Research and Treatment of Cancer - EORTC2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
UMC Utrecht2
Actuate Therapeutics Inc.1
AstraZeneca1
Daiichi Sankyo1
Partner Therapeutics, Inc.1
SciClone Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms17
Carcinoma, Non-Small-Cell Lung4
Breast Neoplasms3
Colorectal Neoplasms3
Head and Neck Neoplasms3
Melanoma3
Carcinoma, Renal Cell2
Cholangiocarcinoma2
Lung Neoplasms2
Neoplasms2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.